• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Lee Schwartzberg: How OneOncology Will Help Community Practices Navigate Cancer Care Landscape

Video

Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, explains how partnerships like OneOncology can help community practices adapt to the rapidly changing cancer care and diagnostic landscape.

Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, explains how partnerships like OneOncology can help community practices adapt to the rapidly changing cancer care and diagnostic landscape.

Transcript

How can partnerships like OneOncology help community practices adapt to the rapidly changing and complex cancer care and diagnostic landscape?

OneOncology is a new company that’s physician-led an technology-driven that will allow practices around the country to come together to share best practices to use a common technology platform from the electronic medical record perspective and allow those practices to adapt to the changes in oncology. Those changes have really been dramatic over the last few years and are accelerating now. Whether it’s on the clinical side where every cancer is becoming more complex, OneOncology will deliver the tools to help practitioners and community oncologists deliver the best care possible for state-of-the-art care for their patients.

In addition, OneOncology will allow growth of the practices at a local level because every practices stays as an independent tax ID. So, there’s an overlay, but the practice at the local level knows their local environment best compared to anyone else. OneOncology will also be moving very forcefully into the value-based care and value-based reimbursement world by delivering the tools which will allow practices to understand their costs and understand everything that’s going on in the practice whether it’s clinical, financial, or administrative, so they can be best prepared to move into a world where risk is shared with the practice.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Amy S. Paller, MD, Chair of Dermatology, Feinberg School of Medicine, Northwestern University
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.